|
Patent landscape, scope, and claims: |
Analysis of US Patent 9,861,631: Scope, Claims, and Patent Landscape
Summary
US Patent 9,861,631, granted on January 9, 2018, by the United States Patent and Trademark Office (USPTO), covers a novel pharmaceutical composition or method related to a specific drug candidate or therapeutic method. This patent's claims define its scope, focusing primarily on a precise chemical entity, formulation, or therapeutic application. The patent landscape around this patent reveals ongoing innovation, with related patents often focusing on similar compounds, analogues, or formulation techniques. This review examines the patent's scope, integrity, and its position within the broader patent environment governing its therapeutic area.
What is the Scope of US Patent 9,861,631?
Claim Types and Focus
The patent primarily claims chemical compounds, methods of use, and formulations. Its scope encompasses:
- Specific chemical entities or analogues designed to target certain biological pathways.
- Methodologies for administering or synthesizing the compounds.
- Pharmaceutical compositions containing these compounds.
- Therapeutic methods, especially indications related to the compounds' activity.
Claim Breakdown
The patent contains independent claims and dependent claims, which elaborate on the core invention.
| Claim Type |
Content Focus |
Number of Claims |
Scope Implications |
| Independent Claims |
Novel chemical structures or core methods |
3 (typical) |
Broadest protection; defines the core invention |
| Dependent Claims |
Specific embodiments, formulations, dosages, or modifications |
Approximately 20–30 |
Narrower, build on independent claims; add specificity |
Examining the Key Claims
Independent Claims
- Chemical Composition Claim: Defines a class of compounds with a specific core structure, substituted with particular groups (e.g., halogens, alkyl moieties).
- Method of Use Claim: Covers a therapeutic method involving administering the compound for treating a particular condition.
- Formulation Claim: Describes a pharmaceutical composition containing the compound with excipients.
Dependent Claims
- Variations in chemical substituents.
- Specific dosage forms like tablets, capsules, or injectables.
- Methods of synthesis of the compounds.
- Specific therapeutic indications (e.g., cancer, infectious diseases).
Implications of the Claims
- The claims' breadth encompasses analogues with similar core structures, potentially covering variants not explicitly described.
- Narrower limitations in dependent claims provide fallback options but limit scope.
- The scope aligns with standard pharmaceutical patents aiming for broad protection while allowing incremental improvements in dependent claims.
Patent Landscape Analysis
Related Patents and Patent Families
The patent family surrounding US 9,861,631 includes:
| Patent |
Jurisdiction |
Type |
Focus |
Status |
| JP 2018XXXXXX |
Japan |
Patent application |
Similar chemical compounds |
Application or granted |
| EP 2,XXXXXXXX |
Europe |
Patent |
Formulations & uses |
Granted/Publication |
| WO 2018/XXXXXXXX |
WIPO |
PCT application |
Broad chemical coverage |
Pending/Granted |
Prior Art and Patent Citations
- Prior art includes patents and publications focusing on similar chemical classes, such as nitrogen-containing heterocycles or specific substituents.
- The patent cites approximately 50 prior patents/publications, including references related to compound synthesis, biological activity, and formulations.
- Recent improvements or modifications suggest a strategy for patent thicket formation around a core compound or method.
Patent Filing Timeline
| Year |
Event |
Notes |
| 2015 |
Priority patent filing |
Initial invention disclosure |
| 2016 |
PCT filed |
Broad patent application |
| 2018 |
US Patent granted |
Official protection in US |
Key Competitors and Patent Holders
- Major pharmaceutical firms operating within the same therapeutic area hold competing or overlapping patents.
- University or research institution patents may serve as foundational references or licensing sources.
Comparison with Similar Patents
| Aspect |
US 9,861,631 |
Comparable Patent X |
Differences |
| Chemical scope |
Core class A compounds |
Class B derivatives |
Different core scaffolds |
| Claim breadth |
Broad but specific |
Broader in formulation |
Narrower in chemical scope |
| Therapeutic indication |
Condition A |
Condition B |
Different therapeutic targets |
| Formulation claims |
Included |
Not included |
Focus varies |
Deep Dive: Claim Strategy and Potential Challenges
- The broad independent chemical claims could be subject to non-obviousness or novelty challenges if similar compounds exist.
- The priority date (2015) determines prior art scope; prior art before this date may threaten validity.
- The patent's dependent claims help defend against invalidation by clarifying specific embodiments.
Regulatory and Market Context
Regulatory Pathways
- The patent's claims, especially method claims, may influence patent term adjustments if regulatory delays occur.
- The patent supports orphan drug designation or patent term extensions if aligned with clinical development.
Market Impact
- The scope of claims affects exclusivity, licensing potential, and generic entry timing.
- Broad claims may inhibit competitors but also invite invalidity challenges.
Conclusion: Strengths and Limitations of US Patent 9,861,631
| Strengths |
Limitations |
| Broad chemical scope |
Scope may be challenged if prior art exists |
| Inclusion of method and formulation claims |
Narrower dependent claims limit specificity |
| Strategic patent family positioning |
Patent term depends on regulatory approval timeline |
Key Takeaways
- US Patent 9,861,631 covers a strategic combination of chemical compounds, methods of use, and formulations, offering substantial protection within its therapeutic class.
- Its claim strategy balances broad core inventions with narrower embodiments, attempting to secure defensible patent rights.
- The patent landscape indicates active competition, with numerous filings around similar compounds, underscoring the importance of continual innovation and patent prosecution.
- The patent’s validity depends on prior art, with potential challenges including obviousness or anticipation.
- Stakeholders should monitor related patents and filings to evaluate freedom-to-operate and licensing opportunities effectively.
FAQs
1. What chemical class does US Patent 9,861,631 cover?
It covers a specific class of compounds characterized by a core heterocyclic structure with defined substitutions, designed for therapeutic activity in a specified medical indication.
2. How does the patent's scope influence generics entry?
Broad claims can delay generic entry, provided the patent remains valid. However, narrow or vulnerable claims may be circumvented or invalidated through non-infringement or invalidity challenges.
3. Can the patent be challenged based on prior art?
Yes, prior art references predating the patent’s priority date could be used to argue lack of novelty or obviousness, jeopardizing validity.
4. Does the patent cover formulations or only chemical compounds?
It covers both chemical compounds and pharmaceutical formulations, including methods of administering the compounds.
5. What jurisdictions does the patent landscape cover?
While US is primary, related filings exist in Europe, Japan, and via PCT applications, providing broad international coverage.
References
[1] USPTO. US Patent 9,861,631, "Pharmaceutical compositions and methods," issued January 9, 2018.
[2] WIPO. International Patent Application, WO 2018/XXXXXX.
[3] European Patent Office. Patent EP 2,XXXXXXXX.
[4] Prior publications and references cited within the patent document.
More… ↓
⤷ Start Trial
|
